Pre-order Enquiry
Request Free Sample
Global Monoclonal Antibody Treatment Market Size, Status and Forecast 2021-2027
SKU ID : QYR-19329708 | Publishing Date : 13-Oct-2021 | No. of pages : 105
Detailed TOC of Global Monoclonal Antibody Treatment Market Size, Status and Forecast 2021-2027
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Monoclonal Antibody Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cancer
1.2.3 Autoimmune Diseases
1.2.4 Exogenous Infection
1.2.5 Hematological Diseases
1.3 Market by Application
1.3.1 Global Monoclonal Antibody Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Monoclonal Antibody Treatment Market Perspective (2016-2027)
2.2 Monoclonal Antibody Treatment Growth Trends by Regions
2.2.1 Monoclonal Antibody Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Monoclonal Antibody Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Monoclonal Antibody Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Monoclonal Antibody Treatment Industry Dynamic
2.3.1 Monoclonal Antibody Treatment Market Trends
2.3.2 Monoclonal Antibody Treatment Market Drivers
2.3.3 Monoclonal Antibody Treatment Market Challenges
2.3.4 Monoclonal Antibody Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Monoclonal Antibody Treatment Players by Revenue
3.1.1 Global Top Monoclonal Antibody Treatment Players by Revenue (2016-2021)
3.1.2 Global Monoclonal Antibody Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Monoclonal Antibody Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Monoclonal Antibody Treatment Revenue
3.4 Global Monoclonal Antibody Treatment Market Concentration Ratio
3.4.1 Global Monoclonal Antibody Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Monoclonal Antibody Treatment Revenue in 2020
3.5 Monoclonal Antibody Treatment Key Players Head office and Area Served
3.6 Key Players Monoclonal Antibody Treatment Product Solution and Service
3.7 Date of Enter into Monoclonal Antibody Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Monoclonal Antibody Treatment Breakdown Data by Type
4.1 Global Monoclonal Antibody Treatment Historic Market Size by Type (2016-2021)
4.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Type (2022-2027)
5 Monoclonal Antibody Treatment Breakdown Data by Application
5.1 Global Monoclonal Antibody Treatment Historic Market Size by Application (2016-2021)
5.2 Global Monoclonal Antibody Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Monoclonal Antibody Treatment Market Size (2016-2027)
6.2 North America Monoclonal Antibody Treatment Market Size by Type
6.2.1 North America Monoclonal Antibody Treatment Market Size by Type (2016-2021)
6.2.2 North America Monoclonal Antibody Treatment Market Size by Type (2022-2027)
6.2.3 North America Monoclonal Antibody Treatment Market Size by Type (2016-2027)
6.3 North America Monoclonal Antibody Treatment Market Size by Application
6.3.1 North America Monoclonal Antibody Treatment Market Size by Application (2016-2021)
6.3.2 North America Monoclonal Antibody Treatment Market Size by Application (2022-2027)
6.3.3 North America Monoclonal Antibody Treatment Market Size by Application (2016-2027)
6.4 North America Monoclonal Antibody Treatment Market Size by Country
6.4.1 North America Monoclonal Antibody Treatment Market Size by Country (2016-2021)
6.4.2 North America Monoclonal Antibody Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Monoclonal Antibody Treatment Market Size (2016-2027)
7.2 Europe Monoclonal Antibody Treatment Market Size by Type
7.2.1 Europe Monoclonal Antibody Treatment Market Size by Type (2016-2021)
7.2.2 Europe Monoclonal Antibody Treatment Market Size by Type (2022-2027)
7.2.3 Europe Monoclonal Antibody Treatment Market Size by Type (2016-2027)
7.3 Europe Monoclonal Antibody Treatment Market Size by Application
7.3.1 Europe Monoclonal Antibody Treatment Market Size by Application (2016-2021)
7.3.2 Europe Monoclonal Antibody Treatment Market Size by Application (2022-2027)
7.3.3 Europe Monoclonal Antibody Treatment Market Size by Application (2016-2027)
7.4 Europe Monoclonal Antibody Treatment Market Size by Country
7.4.1 Europe Monoclonal Antibody Treatment Market Size by Country (2016-2021)
7.4.2 Europe Monoclonal Antibody Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Monoclonal Antibody Treatment Market Size (2016-2027)
8.2 Asia-Pacific Monoclonal Antibody Treatment Market Size by Type
8.2.1 Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Monoclonal Antibody Treatment Market Size by Application
8.3.1 Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region
8.4.1 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Monoclonal Antibody Treatment Market Size (2016-2027)
9.2 Latin America Monoclonal Antibody Treatment Market Size by Type
9.2.1 Latin America Monoclonal Antibody Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Monoclonal Antibody Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Monoclonal Antibody Treatment Market Size by Type (2016-2027)
9.3 Latin America Monoclonal Antibody Treatment Market Size by Application
9.3.1 Latin America Monoclonal Antibody Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Monoclonal Antibody Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Monoclonal Antibody Treatment Market Size by Application (2016-2027)
9.4 Latin America Monoclonal Antibody Treatment Market Size by Country
9.4.1 Latin America Monoclonal Antibody Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Monoclonal Antibody Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Monoclonal Antibody Treatment Market Size (2016-2027)
10.2 Middle East & Africa Monoclonal Antibody Treatment Market Size by Type
10.2.1 Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Monoclonal Antibody Treatment Market Size by Application
10.3.1 Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country
10.4.1 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Monoclonal Antibody Treatment Introduction
11.1.4 Pfizer Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Bayer
11.2.1 Bayer Company Details
11.2.2 Bayer Business Overview
11.2.3 Bayer Monoclonal Antibody Treatment Introduction
11.2.4 Bayer Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.2.5 Bayer Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Monoclonal Antibody Treatment Introduction
11.3.4 Sanofi Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.3.5 Sanofi Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Monoclonal Antibody Treatment Introduction
11.4.4 Merck Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.4.5 Merck Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Monoclonal Antibody Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Roche
11.6.1 Roche Company Details
11.6.2 Roche Business Overview
11.6.3 Roche Monoclonal Antibody Treatment Introduction
11.6.4 Roche Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.6.5 Roche Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Monoclonal Antibody Treatment Introduction
11.7.4 Novartis Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Monoclonal Antibody Treatment Introduction
11.8.4 AbbVie Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.8.5 AbbVie Recent Development
11.9 Shanghai Junshi Biosciences Co.,Ltd
11.9.1 Shanghai Junshi Biosciences Co.,Ltd Company Details
11.9.2 Shanghai Junshi Biosciences Co.,Ltd Business Overview
11.9.3 Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Introduction
11.9.4 Shanghai Junshi Biosciences Co.,Ltd Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.9.5 Shanghai Junshi Biosciences Co.,Ltd Recent Development
11.10 Innovent Biologics
11.10.1 Innovent Biologics Company Details
11.10.2 Innovent Biologics Business Overview
11.10.3 Innovent Biologics Monoclonal Antibody Treatment Introduction
11.10.4 Innovent Biologics Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.10.5 Innovent Biologics Recent Development
11.11 Jiangsu Hengrui Medicine Co.,Ltd.
11.11.1 Jiangsu Hengrui Medicine Co.,Ltd. Company Details
11.11.2 Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
11.11.3 Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Introduction
11.11.4 Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.11.5 Jiangsu Hengrui Medicine Co.,Ltd. Recent Development
11.12 BeiGene, Ltd.
11.12.1 BeiGene, Ltd. Company Details
11.12.2 BeiGene, Ltd. Business Overview
11.12.3 BeiGene, Ltd. Monoclonal Antibody Treatment Introduction
11.12.4 BeiGene, Ltd. Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.12.5 BeiGene, Ltd. Recent Development
11.13 Grand Pharmaceutical (China) Co., Ltd
11.13.1 Grand Pharmaceutical (China) Co., Ltd Company Details
11.13.2 Grand Pharmaceutical (China) Co., Ltd Business Overview
11.13.3 Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Introduction
11.13.4 Grand Pharmaceutical (China) Co., Ltd Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.13.5 Grand Pharmaceutical (China) Co., Ltd Recent Development
11.14 Henlius
11.14.1 Henlius Company Details
11.14.2 Henlius Business Overview
11.14.3 Henlius Monoclonal Antibody Treatment Introduction
11.14.4 Henlius Revenue in Monoclonal Antibody Treatment Business (2016-2021)
11.14.5 Henlius Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Figures, Tables and Charts Available in Global Monoclonal Antibody Treatment Market Size, Status and Forecast 2021-2027
List of TablesTable 1. Global Monoclonal Antibody Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cancer
Table 3. Key Players of Autoimmune Diseases
Table 4. Key Players of Exogenous Infection
Table 5. Key Players of Hematological Diseases
Table 6. Global Monoclonal Antibody Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Monoclonal Antibody Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Monoclonal Antibody Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Monoclonal Antibody Treatment Market Share by Regions (2016-2021)
Table 10. Global Monoclonal Antibody Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Monoclonal Antibody Treatment Market Share by Regions (2022-2027)
Table 12. Monoclonal Antibody Treatment Market Trends
Table 13. Monoclonal Antibody Treatment Market Drivers
Table 14. Monoclonal Antibody Treatment Market Challenges
Table 15. Monoclonal Antibody Treatment Market Restraints
Table 16. Global Monoclonal Antibody Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Monoclonal Antibody Treatment Market Share by Players (2016-2021)
Table 18. Global Top Monoclonal Antibody Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Treatment as of 2020)
Table 19. Ranking of Global Top Monoclonal Antibody Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Monoclonal Antibody Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Monoclonal Antibody Treatment Product Solution and Service
Table 23. Date of Enter into Monoclonal Antibody Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Monoclonal Antibody Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Monoclonal Antibody Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Monoclonal Antibody Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Monoclonal Antibody Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Monoclonal Antibody Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Monoclonal Antibody Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Monoclonal Antibody Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Monoclonal Antibody Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Monoclonal Antibody Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Monoclonal Antibody Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Monoclonal Antibody Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Monoclonal Antibody Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Monoclonal Antibody Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Monoclonal Antibody Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Monoclonal Antibody Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Monoclonal Antibody Treatment Product
Table 66. Pfizer Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Bayer Company Details
Table 69. Bayer Business Overview
Table 70. Bayer Monoclonal Antibody Treatment Product
Table 71. Bayer Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 72. Bayer Recent Development
Table 73. Sanofi Company Details
Table 74. Sanofi Business Overview
Table 75. Sanofi Monoclonal Antibody Treatment Product
Table 76. Sanofi Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 77. Sanofi Recent Development
Table 78. Merck Company Details
Table 79. Merck Business Overview
Table 80. Merck Monoclonal Antibody Treatment Product
Table 81. Merck Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 82. Merck Recent Development
Table 83. GlaxoSmithKline Company Details
Table 84. GlaxoSmithKline Business Overview
Table 85. GlaxoSmithKline Monoclonal Antibody Treatment Product
Table 86. GlaxoSmithKline Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 87. GlaxoSmithKline Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Monoclonal Antibody Treatment Product
Table 91. Roche Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 92. Roche Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Monoclonal Antibody Treatment Product
Table 96. Novartis Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 97. Novartis Recent Development
Table 98. AbbVie Company Details
Table 99. AbbVie Business Overview
Table 100. AbbVie Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 101. AbbVie Recent Development
Table 102. Shanghai Junshi Biosciences Co.,Ltd Company Details
Table 103. Shanghai Junshi Biosciences Co.,Ltd Business Overview
Table 104. Shanghai Junshi Biosciences Co.,Ltd Monoclonal Antibody Treatment Product
Table 105. Shanghai Junshi Biosciences Co.,Ltd Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 106. Shanghai Junshi Biosciences Co.,Ltd Recent Development
Table 107. Innovent Biologics Company Details
Table 108. Innovent Biologics Business Overview
Table 109. Innovent Biologics Monoclonal Antibody Treatment Product
Table 110. Innovent Biologics Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 111. Innovent Biologics Recent Development
Table 112. Jiangsu Hengrui Medicine Co.,Ltd. Company Details
Table 113. Jiangsu Hengrui Medicine Co.,Ltd. Business Overview
Table 114. Jiangsu Hengrui Medicine Co.,Ltd. Monoclonal Antibody Treatment Product
Table 115. Jiangsu Hengrui Medicine Co.,Ltd. Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 116. Jiangsu Hengrui Medicine Co.,Ltd. Recent Development
Table 117. BeiGene, Ltd. Company Details
Table 118. BeiGene, Ltd. Business Overview
Table 119. BeiGene, Ltd. Monoclonal Antibody Treatment Product
Table 120. BeiGene, Ltd. Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 121. BeiGene, Ltd. Recent Development
Table 122. Grand Pharmaceutical (China) Co., Ltd Company Details
Table 123. Grand Pharmaceutical (China) Co., Ltd Business Overview
Table 124. Grand Pharmaceutical (China) Co., Ltd Monoclonal Antibody Treatment Product
Table 125. Grand Pharmaceutical (China) Co., Ltd Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 126. Grand Pharmaceutical (China) Co., Ltd Recent Development
Table 127. Henlius Company Details
Table 128. Henlius Business Overview
Table 129. Henlius Monoclonal Antibody Treatment Product
Table 130. Henlius Revenue in Monoclonal Antibody Treatment Business (2016-2021) & (US$ Million)
Table 131. Henlius Recent Development
Table 132. Research Programs/Design for This Report
Table 133. Key Data Information from Secondary Sources
Table 134. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Monoclonal Antibody Treatment Market Share by Type: 2020 VS 2027
Figure 2. Cancer Features
Figure 3. Autoimmune Diseases Features
Figure 4. Exogenous Infection Features
Figure 5. Hematological Diseases Features
Figure 6. Global Monoclonal Antibody Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Monoclonal Antibody Treatment Report Years Considered
Figure 11. Global Monoclonal Antibody Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Monoclonal Antibody Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Monoclonal Antibody Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Monoclonal Antibody Treatment Market Share by Regions (2022-2027)
Figure 15. Global Monoclonal Antibody Treatment Market Share by Players in 2020
Figure 16. Global Top Monoclonal Antibody Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Monoclonal Antibody Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Monoclonal Antibody Treatment Revenue in 2020
Figure 18. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Monoclonal Antibody Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Monoclonal Antibody Treatment Market Share by Type (2016-2027)
Figure 22. North America Monoclonal Antibody Treatment Market Share by Application (2016-2027)
Figure 23. North America Monoclonal Antibody Treatment Market Share by Country (2016-2027)
Figure 24. United States Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Monoclonal Antibody Treatment Market Share by Type (2016-2027)
Figure 28. Europe Monoclonal Antibody Treatment Market Share by Application (2016-2027)
Figure 29. Europe Monoclonal Antibody Treatment Market Share by Country (2016-2027)
Figure 30. Germany Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Monoclonal Antibody Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Monoclonal Antibody Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Monoclonal Antibody Treatment Market Share by Region (2016-2027)
Figure 40. China Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Monoclonal Antibody Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Monoclonal Antibody Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Monoclonal Antibody Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Monoclonal Antibody Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Monoclonal Antibody Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Monoclonal Antibody Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Monoclonal Antibody Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 60. Bayer Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 62. Merck Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 65. Novartis Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 66. AbbVie Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 67. Shanghai Junshi Biosciences Co.,Ltd Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 68. Innovent Biologics Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 69. Jiangsu Hengrui Medicine Co.,Ltd. Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 70. BeiGene, Ltd. Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 71. Grand Pharmaceutical (China) Co., Ltd Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 72. Henlius Revenue Growth Rate in Monoclonal Antibody Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
Keyplayers in Global Monoclonal Antibody Treatment Market Size, Status and Forecast 2021-2027
PfizerBayer
Sanofi
Merck
GlaxoSmithKline
Roche
Novartis
AbbVie
Shanghai Junshi Biosciences Co.,Ltd
Innovent Biologics
Jiangsu Hengrui Medicine Co.,Ltd.
BeiGene, Ltd.
Grand Pharmaceutical (China) Co., Ltd
Henlius
Request Sample
Request Discount
